Evotec SE (EVO) Receives Grants to Advance Tuberculosis Treatment

Go back to Evotec SE (EVO) Receives Grants to Advance Tuberculosis Treatment
EATON VANCE OHIO MUNI INCOME T (NASDAQ: EVO) Delayed: 2.65 +0.09 (3.52%)
Previous Close $2.56    52 Week High $16.39 
Open $2.62    52 Week Low $13.22 
Day High $2.67    P/E N/A 
Day Low $2.61    EPS $-1.61 
Volume 28,432